Delivering tomorrow’s
genetic medicines,


With the emergence of gene therapies, we are at a crucial turning point in human history.

In our lifetimes, we will see major diseases become treatable or curable thanks to this new therapeutic approach.

At NanoVation TherapeuticsTM (NTx), we are making this future a reality by enabling the safe and efficient delivery of genetic medicines to target tissues in the body.


To harness the power of genetic medicines to prevent, treat or cure diseases


To be the premier innovator for nucleic acid therapeutics

Our next-generation platform technologies use lipid nanoparticles to deliver nucleic acids to a variety of tissues

NTx develops scalable, nucleic acid-agnostic lipid nanoparticle (LNP) formulations customized for specific targets, payloads and routes of administration.

NanoVation Therapeuticsprovides a leading one-stop-shop IP portfolio to empower your genetic medicines

mRNA modifications

Specialty (ionizable) lipids

Surface modifications

LNP compositions

Our multidisciplinary team includes world-leading experts in lipid chemistry, RNA design and nucleic acid delivery

NanoVation Therapeutics is headquartered in Vancouver, BC, Canada

Founded in Vancouver, NanoVation Therapeutics is establishing an international chain of innovation hubs (NanoVation GENErators) in strategic locations worldwide.

International headquarters
4th Floor, 2405 Wesbrook Mall, Vancouver BC V6T 1Z3, Canada

NanoVation Therapeutics™

4th Floor, 2405 Wesbrook Mall
Vancouver BC V6T 1Z3

UK NanoVation GENErator™
Harwell Science and Innovation Campus, Oxford, UK OX11 0FA

UK NanoVation GENErator™

Hartwell Science & Innovation Campus
Oxford, Didcot OX11 0RL
United Kingdom